Could The Long Deckline In Biotechnology M&A Be Ending
There were at least 14 biopharma purchases totaling $50 million or more between April and June, which is at least twice as many as...
Acute Allergies To Novavax COVID Jabs Get Listed By The EU
The COVID-19 vaccine from Novavax Inc. may cause serious allergic reactions, according to the European Medicines Agency. The vaccine's product label in the United...
No Rush In Indian Generic Drug Firms To Launch COVID Products
Indian generic drugmakers are delaying more investments in COVID-related drugs after making gains in the last two years, according to certain pharmaceutical industry insiders.
BDR...
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
An innovative system for monitoring chromosomal fragility and copy number alterations in particularly lethal tumours was described earlier this July by researchers from Cambridge University...
FDA Clears Novavax COVID-19 Vaccine As Fourth Option In US
As infections in the U.S. continue to be at high levels, the Food and Drug Administration on 13th July approved a fourth vaccination for...
Indian Pharma Business May Increase 8-11%, Predicts Alkem
When the epidemic subsides, Alkem Laboratories predicts that inflationary pressures and shifting regulatory standards will be the primary concerns to keep an eye on,...
Lonza To Construct $518mn Fill-Finish Plant In Switzerland
Lonza, a major CDMO, is to invest $518 million in a new, massive fill-finish manufacturing facility in Stein, Switzerland. According to the firm, the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...